Join
Live feed
·
INSIDERFilingvia Quantisnow
Reata Pharmaceuticals Inc. logo

Meyer Colin John returned 81,633 shares to the company, closing all direct ownership in the company (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
RETA· Reata Pharmaceuticals Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track RETA (Reata Pharmaceuticals Inc.) and more on Quantisnow.